Skip to main content

Table 3 Subgroup analysis of liver cirrhosis and HBsAg

From: Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis

Subgroups

No. of studies

Pooled OR (95% CI)

P value

Heterogeneity

I 2

P value

Liver cirrhosis

 Asia

6

1.27 (0.72–2.25)

0.42

42%

0.12

 Egypt

2

10.03 (0.74–136.23)

0.08

63%

0.10

HBsAg

 Asia

6

0.91 (0.61–1.34)

0.62

38%

0.15

 Egypt

1

0.24 (0.06–0.97)

0.04

  1. HBsAg hepatitis B surface antigen, OR odds ratio, CI confidence interval